Literature DB >> 24606323

Individualizing HbA1c targets for patients with diabetes: impact of an automated algorithm within a primary care network.

S A Berkowitz1, S J Atlas, R W Grant, D J Wexler.   

Abstract

AIMS: To develop glycaemic goal individualization algorithms and assess potential impact on a healthcare system and different segments of the population with diabetes.
METHODS: A cross-sectional observational study of patients with diabetes in a primary care network age > 18 years with an HbA1c measured between 1 January and 31 December 2011. We applied diabetes guidelines to create targeted algorithms 1 and 2, which assigned HbA1c goals based on age, duration of diabetes (< 15 years or < 10 years), diabetes complications and Charlson co-morbidity score (< 6 or < 4) [targeted algorithm 2 was designed to assign more patients a goal < 64 mmol/mol (8.0%) than targeted algorithm 1]. Each patient's HbA1c was compared with these targeted goals and to the 'standard' goal < 53 mmol/mol (7.0%). Agreement was tested using McNemar's test.
RESULTS: Overall, 55.7% of 12 199 patients would be considered controlled under the 'standard' approach, 61.2% under targeted algorithm 1 and 67.5% under targeted algorithm 2. Targeted algorithm 1 reclassified 1213 (23.6%) patients considered uncontrolled under the standard approach to controlled, P < 0.001. Targeted algorithm 2 reclassified 1844 (35.2%) patients, P < 0.001. Compared with those controlled under the standard goal, there was no significant difference in the proportion of those controlled using targeted goals who had Medicaid, had less than a high school diploma or received primary care in a federally qualified health centre.
CONCLUSIONS: Two automated targeted algorithms would reclassify one quarter to one third of patients from uncontrolled to controlled within a primary care network without differentially affecting vulnerable patient subgroups.
© 2014 The Authors. Diabetic Medicine © 2014 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24606323      PMCID: PMC4425735          DOI: 10.1111/dme.12427

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  28 in total

1.  Glycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetes.

Authors:  Gregory A Nichols; Teresa M Kimes; Joyce B Harp; Tzuyung Doug Kou; Kimberly G Brodovicz
Journal:  Diabetes Care       Date:  2012-01-25       Impact factor: 19.112

2.  Sudden acceleration of diabetes quality measures.

Authors:  Leonard Pogach; David C Aron
Journal:  JAMA       Date:  2011-02-16       Impact factor: 56.272

3.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.

Authors:  Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

Review 4.  Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.

Authors:  Faramarz Ismail-Beigi; Etie Moghissi; Margaret Tiktin; Irl B Hirsch; Silvio E Inzucchi; Saul Genuth
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391

5.  Relationship between patient panel characteristics and primary care physician clinical performance rankings.

Authors:  Clemens S Hong; Steven J Atlas; Yuchiao Chang; S V Subramanian; Jeffrey M Ashburner; Michael J Barry; Richard W Grant
Journal:  JAMA       Date:  2010-09-08       Impact factor: 56.272

Review 6.  Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Authors:  Cecilia C Low Wang; Jane E B Reusch
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

7.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

8.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 10.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112

View more
  6 in total

Review 1.  The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review.

Authors:  Samuel J Westall; Ram Prakash Narayanan; Simon Watmough; Greg Irving; Niall Furlong; Sid McNulty; Sumudu Bujawansa; Kevin Hardy
Journal:  Clin Med (Lond)       Date:  2022-04-20       Impact factor: 5.410

2.  Addressing Unmet Basic Resource Needs as Part of Chronic Cardiometabolic Disease Management.

Authors:  Seth A Berkowitz; Amy Catherine Hulberg; Sara Standish; Gally Reznor; Steven J Atlas
Journal:  JAMA Intern Med       Date:  2017-02-01       Impact factor: 21.873

3.  Food Insecurity and Cardiovascular Health in Pregnant Women: Results From the Food for Families Program, Chelsea, Massachusetts, 2013-2015.

Authors:  Mary E Morales; Michael H Epstein; Danelle E Marable; Sarah A Oo; Seth A Berkowitz
Journal:  Prev Chronic Dis       Date:  2016-11-03       Impact factor: 2.830

4.  Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures.

Authors:  Ildiko Lingvay; Jason Chao; Mehul R Dalal; Luigi F Meneghini
Journal:  Diabetes Technol Ther       Date:  2017-05-03       Impact factor: 6.118

5.  Natural Language Processing to Improve Prediction of Incident Atrial Fibrillation Using Electronic Health Records.

Authors:  Jeffrey M Ashburner; Yuchiao Chang; Xin Wang; Shaan Khurshid; Christopher D Anderson; Kumar Dahal; Dana Weisenfeld; Tianrun Cai; Katherine P Liao; Kavishwar B Wagholikar; Shawn N Murphy; Steven J Atlas; Steven A Lubitz; Daniel E Singer
Journal:  J Am Heart Assoc       Date:  2022-07-29       Impact factor: 6.106

6.  Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease.

Authors:  Daniel M Blumenthal; Sidney E Howard; Jennifer Searl Como; Sandra M O'Keefe; Steven J Atlas; Daniel M Horn; Neil W Wagle; Jason H Wasfy; Robert W Yeh; Joshua P Metlay
Journal:  JAMA Netw Open       Date:  2021-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.